Take Home Quiz 1 Please complete the quiz below prior to the session. Use the Multiple Primary and Histology Rules

Similar documents
Quiz. b. 4 High grade c. 9 Unknown

Quiz 1: Terminology and Anatomy

Exercise. Discharge Summary

Case Scenario 1. Pathology report Specimen from mediastinoscopy Final Diagnosis : Metastatic small cell carcinoma with residual lymphatic tissue

Case Scenario 1 Discharge Summary Pathology Report Final Diagnosis: Oncology Consult

Case Scenario 1 Worksheet. Primary Site C44.4 Morphology 8743/3 Laterality 0 Stage/ Prognostic Factors

Case Scenario 1. 2/15/2011 The patient received IMRT 45 Gy at 1.8 Gy per fraction for 25 fractions.

Case Scenario 1 Discharge Summary Pathology Report Final Diagnosis: Oncology Consult

ACOS Inquiry and Response Selected Inquires CS Tumor Size/Extension Evaluation, CS Lymph Nodes Evaluation, CS Metastasis at Diagnosis Evaluation *

A patient with recurrent bladder cancer presents with the following history:

Case Scenario 1: Thyroid

Exercise 15: CSv2 Data Item Coding Instructions ANSWERS

Q&A. Fabulous Prizes. Collecting Cancer Data: Bladder, Renal Pelvis, and Ureter 5/2/13. NAACCR Webinar Series

Case Scenario 1: This case has been slightly modified from the case presented during the live session to add clarity.

Histology Coding ANSWERS

SEER Summary Stage Still Here!

Case Scenario 1. The patient has now completed his neoadjuvant chemoradiation and has been cleared for surgery.

Case Scenario 1 History and Physical 3/15/13 Imaging Pathology

8. The polyp in the illustration can be described as (circle all that apply) a. Exophytic b. Pedunculated c. Sessile d. Frank

Case Scenario 1: This case has been slightly modified from the case presented during the live session to add clarity.

11/21/13 CEA: 1.7 WNL

Case Scenario 1. The patient agreed to a CT guided biopsy of the left upper lobe mass. This was performed and confirmed non-small cell carcinoma.

Quiz 1. Assign Race 1, Race 2 and Spanish Hispanic Origin to the following scenarios.

Case Scenario 1. 4/19/13 Bone Scan: No scintigraphic findings to suggest skeletal metastases.

FINE NEEDLE ASPIRATION OF ENLARGED LYMPH NODE: Metastatic squamous cell carcinoma

Abstracting Upper GI Cancer Incidence and Treatment Data Quiz 1 Multiple Primary and Histologies Case 1 Final Pathology:

Case #1: 75 y/o Male (treated and followed by prostate cancer oncology specialist ).

Coding Pitfalls 9/1/2011. Coding Pitfalls Questions. Fabulous Prizes!!! September 1, NAACCR Webinar Series 1

Bladder Case 1 SURGICAL PATHOLOGY REPORT. Procedure: Cystoscopy, transurethral resection of bladder tumor (TURBT)

Prostate Overview Quiz

Multiple Primary Quiz

QUIZZES WITH ANSWERS FOR COLLECTING CANCER DATA: PHARYNX

Collecting Cancer Data: Breast. Prizes! Collecting Cancer Data: Breast 8/4/ NAACCR Webinar Series 1. NAACCR Webinar Series

Boot Camp Case Scenarios

Melanoma Case Scenario 1

1/25/13 Right partial nephrectomy followed by completion right radical nephrectomy.

Q&A. Fabulous Prizes. Collecting Cancer Data: Breast 4/4/13. NAACCR Webinar Series Collecting Cancer Data Breast

Pathology: Grade 1 infiltrating ductal carcinoma with associated DCIS, Lymphvascular invasion present. ER+, PR+. Her 2/ IHC 1+, negative

QUIZZES WITH ANSWERS FOR COLLECTING CANCER DATA: PHARYNX

Case Scenario 1. Pathology: Specimen type: Incisional biopsy of the glottis Histology: Moderately differentiated squamous cell carcinoma

Melanoma Case Scenario 1

Case Scenario 1: Breast

Prostate Case Scenario 1

Case Scenario #1 Larynx

Cancers of unknown primary : Knowing the unknown. Prof. Ahmed Hossain Professor of Medicine SSMC

Coding Pitfalls 9/11/14

Guidelines for Assigning Summary Stage 2000

Lung. 10/24/13 Chest X-ray: 2.9 cm mass like density in the inferior lingular segment worrisome for neoplasm. Malignancy cannot be excluded.

A Practicum Approach to CS: GU Prostate, Testis, Bladder, Kidney, Renal Pelvis. Jennifer Ruhl, RHIT, CCS, CTR Janet Stengel, RHIA, CTR

MPH Quiz. 1. How many primaries are present based on this pathology report? 2. What rule is this based on?

Karoline Nowillo, MD. February 1, 2008

Case Scenario 1. Discharge Summary

5/26/16: CT scan of the abdomen showed a multinodular liver disease highly suspicious for metastasis and hydronephrosis of the right kidney.

Q&A. Overview. Collecting Cancer Data: Prostate. Collecting Cancer Data: Prostate 5/5/2011. NAACCR Webinar Series 1

Breast Cancer. Most common cancer among women in the US. 2nd leading cause of death in women. Mortality rates though have declined

Breast Cancer. Saima Saeed MD

Collaborative Stage for TNM 7 - Revised 12/02/2009 [ Schema ]

ACRIN 6666 Therapeutic Surgery Form

Cervical Cancer 3/25/2019. Abnormal vaginal bleeding

Case Scenario 1. History

Testicular Malignancies /8/15

ABSITE Review. RTC Conference Christina Bailey January 15, 2009

Thyroid and Adrenal Gland

Breast Cancer Diagnosis, Treatment and Follow-up

Interactive Discussion of Part I CS Coding Instructions: Working the Cases

Respiratory Interactive Session. Elaine Borg

came from a carcinoma and in 12 from a sarcoma. Ninety lesions were intrapulmonary and the as the chest wall and pleura. Details of the primary

DATA STANDARDS AND QUALITY CONTROL MEMORANDUM DSQC #

List of Available TMAs in the PRN

Pancreas Quizzes c. Both A and B a. Directly into the blood stream (not using ducts)

Case Scenario 1. 7/13/12 Anterior floor of mouth biopsy: Infiltrating squamous cell carcinoma, not completely excised.

2007 New Data Items. Slide 1. In this presentation we will discuss five new data items that were introduced with the 2007 MPH Coding Rules.

MUSCLE - INVASIVE AND METASTATIC BLADDER CANCER

Q: How do you clinically code the N if the nodes are stated to be positive on mammogram/us or other imaging? No biopsy of nodes was done.

FINALIZED SEER SINQ QUESTIONS April July, 2017

Case Scenario. 7/13/12 Anterior floor of mouth biopsy: Infiltrating squamous cell carcinoma, not completely excised.

Thyroid Nodule. Disclosure. Learning Objectives P A P A P A 3/18/2014. Nothing to disclose.

Case Report Tumor-to-Tumor Metastasis: Lung Carcinoma Metastasizing to Thyroid Neoplasms

Radiology Pathology Conference

Tumor Markers Yesterday, Today & Tomorrow. Steven E. Zimmerman M.D. Vice President & Chief Medical Director

Quality ID #263: Preoperative Diagnosis of Breast Cancer National Quality Strategy Domain: Effective Clinical Care

CAP Cancer Protocol and ecc Summary of Changes for August 2014 Thyroid Agile Release

CS Evaluation Fields. Outline of Presentation. Purpose of Evaluation Field. CSv2 Title of Presentation Jan 2011 Lecture Version: 1.

FINALIZED SEER SINQ S MAY 2012

Chapter 2: Initial treatment for endometrial cancer (including histologic variant type)

Case Report Tumor-to-Tumor Metastasis: Lung Carcinoma Metastasizing to Thyroid Neoplasms

4/22/2010. Hakan Korkmaz, MD Assoc. Prof. of Otolaryngology Ankara Dıșkapı Training Hospital-Turkey.

Please complete prior to the webinar. HOSPITAL REGISTRY WEBINAR FEMALE REPRODUCTIVE SYSTEM EXERCISES CASE 1: FEMALE REPRODUCTIVE

What is Cancer? Petra Ketterl, MD Medical Oncology and Functional Medicine

Definition of Synoptic Reporting

Oncology General Principles L A U R I E S I M A R D B R E A S T S U R G I C A L O N C O L O G Y F E L L O W D E C E M B E R

A712(18)- Test slide, Breast cancer tissues with corresponding normal tissues

MUSCLE-INVASIVE AND METASTATIC BLADDER CANCER

2018 New Required Data Items for Hospitals

Collecting Cancer Data: Lung

B REAST STAGING FORM. PATHOLOGIC Extent of disease through completion of definitive surgery. CLINICAL Extent of disease before any treatment

GOALS AND OBJECTIVES BREAST PATHOLOGY

Transcription:

Take Home Quiz 1 Please complete the quiz below prior to the session. Use the Multiple Primary and Histology Rules Case 1 72 year old white female presents with a nodular thyroid. This was biopsied in her primary care physician s office and found to be malignant. She is here for a complete thyroidectomy. Final pathology from total thyroidectomy performed on 7/15/14: Right lobe single papillary thyroid carcinoma, 1.8 cm. Left lobe is positive for multifocal follicular carcinoma. The largest foci measures 0.8 cm. Two lymph nodes submitted are negative for malignancy. 1. How many primaries are present in case 1? 2. What is the histology code? a. 8260/3 b. 8330/3 c. 8340/3 d. Primary 1 8260/3; primary 2 8330/3 Case 2 10/4/14 Surgical Pathology Report Final Diagnosis: Lung, right upper lobectomy two tumor nodules of carcinoma consistent with pulmonary primary identified. One nodule is most likely clear cell carcinoma while the other nodule is consistent with squamous cell carcinoma. 3. How many primaries were present in case 2? 4. What is the histology code? a. 8010/3 b. 8070/3 c. 8310/3 d. Primary 1 8310/3; primary 2 8070/3

Case 3 2/27/11 Pathology Report Gross description: The specimen is labeled bladder tumors and consists of multiple tan brown shaggy fragments of tissue aggregating to 7.6 x 5.5 x 1.2 cm. The specimen is entirely submitted in ten cassettes. Final Diagnosis: Invasive papillary transitional cell carcinoma of bladder. 4/19/14 Pathology Report Gross description: The specimen is labeled bladder tumors and consists of multiple fragments of tissue. Final Diagnosis: Non invasive urothelial carcinoma of bladder. 5. How many primaries were present in case 3? 6. What is the histology code? a. 8120/2 b. 8120/3 c. 8130/3 d. Primary 1 8130/3; Primary 2 8120/2 Case 4 9/3/14 Pathology Report Final diagnosis right breast excisional biopsy: Ductal carcinoma in situ (DCIS), comedo carcinoma type. DCIS directly involves one margin and is very close to but clear of several other margins. 9/17/14 Pathology Report Final Diagnosis right breast simple mastectomy, lumpectomy: Extensive residual intraductal carcinoma, mainly in the lateral half of the lumpectomy specimen. Right axillary sentinel lymph nodes: Two lymph nodes with reactive lymphoid hyperplasia and sinus histiocytosis, with no granuloma and no metastatic tumor. 7. How many primaries were present in case 4? 8. What is the histology code? a. 8500/2 b. 8500/3 c. 8501/2 d. Primary 1 8501/2; primary 2 8500/2

Case 5 A patient has a long history of urinary tract malignancies. How many primaries does this patient have? 6/29/06 non invasive papillary urothelial carcinoma bladder trigone. 1/17/07 non invasive papillary urothelial carcinoma left ureteral orifice (ureter inspected & no tumor in the ureter). 4/13/09 non invasive papillary urothelial carcinoma left ureteral orifice (no tumor in ureter). 3/1/12 non invasive papillary urothelial carcinoma 8130/2 multiple tumors in the bladder; tumor around & within left ureteral orifice; tumor in lower third of ureter up to pelvic brim (tumor in ureter not biopsied) 2/25/13 non invasive papillary urothelial carcinoma multiple bladder lesions; distal ureter lesion (path report calls specimens urinary bladder mucosa biopsy & urinary bladder mucosa, bladder neck biopsy; the op report does not specifically say that the ureter lesion was biopsied). 5/30/14 non invasive papillary urothelial carcinoma multiple bladder lesions. 12/15/14 non invasive papillary urothelial carcinoma multiple bladder lesions; a separate tumor is identified in the distal ureter, but not biopsied. 1/20/15 non invasive papillary urothelial carcinoma left ureterectomy. 9. How many primaries were present in case 4? 10. What is the histology code? a. 8120/2 b. 8120/3 c. Primary 1 8120/2; primary 2 8120/2 d. Primary 1 8130/2; primary 2 8130/2

Take Home Quiz 2 Please complete the quiz below prior to the session. Use CS v02.05. Melanoma Patient had palpable right axillary node but no breast or skin lesions present. Fine needle aspiration of axillary lymph node diagnosed malignant melanoma. Thorough skin examination was done, but no skin lesion was identified. All imaging was normal. Patient had axillary lymph node dissection with 2 of 12 lymph nodes positive for metastatic malignant melanoma. 1. What is the CS Lymph Nodes code? 2. What is the CS Mets at DX code? Colon/rectum Fifty year old male reports for screening colonoscopy. All systems normal; no symptoms of colorectal cancer. Colonoscopy with polypectomy: 1 polyp identified and excised; no other abnormalities. Final diagnosis: Adenocarcinoma in tubular adenoma invades the submucosa of polyp stalk; margins clear. No other treatment needed. 3. What is the code for CS Extension? 4. What is the code for CS Lymph Nodes? Liver MRI: Multiple liver tumors, largest is 4 cm, in both liver lobes; vascular invasion is present. No lymphadenopathy. Abnormalities noted in pelvic bone. Core biopsy of largest liver tumor: Hepatoma, poorly differentiated. Chest x ray: Normal. Bone scan: Metastatic disease in pelvic bone. Liver is cirrhotic. Child Pugh class is C; MELD score is 39. 5. What is the CS Extension code? 6. What is the SSF2 (Fibrosis Score) code?

Lung CT scan: 4 cm tumor, right upper lobe of lung; right mediastinal lymphadenopathy; no pleural effusion Bronchoscopy with right upper lung lobe biopsy: Poorly differentiated adenocarcinoma. Mediastinoscopy with left mediastinal lymph node sampling: 3 of 4 mediastinal lymph nodes positive for metastasis. No surgical resection. 7. What is the code for CS Lymph Nodes? 8. What is the code for CS Lymph Nodes Eval? Testis 10/1/14 Physical exam: 2 month history of right testicular mass. Mass palpated on exam. Most likely testicular cancer. 10/1/14 CT scan chest and abdomen/pelvis: No abnormalities of lung or mediastinum. 2 cm para aortic lymph node mass, malignant. No other abnormalities of abdomen/pelvis. Pre operative LDH, hcg, and AFP within normal limits. 10/15/14 Right orchiectomy: 3 cm seminoma invades tunica albuginea. 11/19/14 Begins adjuvant chemotherapy. 1/28/15 Retroperitoneal lymph node dissection: 2/30 lymph nodes positive for metastasis. 9. What is the code for CS Lymph Nodes? 10. What is the code for CS Lymph Nodes Eval? Uterus Clinical exam & colposcopy: 1 cm visible cervical lesion; no lymphadenopathy Chest x ray: Normal Curettage & cervical biopsy: Squamous cell carcinoma, primarily in situ, with a small component of tumor with 1 mm stromal invasion. Trachelectomy: Residual squamous cell carcinoma in situ; margins clear. 11. What is the code for CS Extension? 12. What is the code for CS Tumor Size/Ext Eval?

Breast 12/1/14 Right breast core biopsy: Infiltrating ductal carcinoma. 12/1/14 HER2 IHC: 2+; borderline HER2 FISH: Ratio 1.2; within normal limits 13. What is the code for SSF8? 14. What is the code for SSF9? 15. What is the code for SSF10? 16. What is the code for SSF11? 17. What is the code for SSF15?